216 related articles for article (PubMed ID: 10438726)
1. CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade.
Tuscano JM; Riva A; Toscano SN; Tedder TF; Kehrl JH
Blood; 1999 Aug; 94(4):1382-92. PubMed ID: 10438726
[TBL] [Abstract][Full Text] [Related]
2. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
Chan VW; Lowell CA; DeFranco AL
Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638
[TBL] [Abstract][Full Text] [Related]
3. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.
Wu HJ; Venkataraman C; Estus S; Dong C; Davis RJ; Flavell RA; Bondada S
J Immunol; 2001 Aug; 167(3):1263-73. PubMed ID: 11466342
[TBL] [Abstract][Full Text] [Related]
4. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
Bobbitt KR; Justement LB
J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
[TBL] [Abstract][Full Text] [Related]
5. Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation.
Tuscano J; Engel P; Tedder TF; Kehrl JH
Blood; 1996 Jun; 87(11):4723-30. PubMed ID: 8639842
[TBL] [Abstract][Full Text] [Related]
6. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
Poe JC; Fujimoto M; Jansen PJ; Miller AS; Tedder TF
J Biol Chem; 2000 Jun; 275(23):17420-7. PubMed ID: 10748054
[TBL] [Abstract][Full Text] [Related]
7. Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells.
Chang CH; Wang Y; Gupta P; Goldenberg DM
MAbs; 2015; 7(1):199-211. PubMed ID: 25484043
[TBL] [Abstract][Full Text] [Related]
8. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
[TBL] [Abstract][Full Text] [Related]
9. CD22 is a negative regulator of B-cell receptor signalling.
Nitschke L; Carsetti R; Ocker B; Köhler G; Lamers MC
Curr Biol; 1997 Feb; 7(2):133-43. PubMed ID: 9016707
[TBL] [Abstract][Full Text] [Related]
10. CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1.
Otipoby KL; Draves KE; Clark EA
J Biol Chem; 2001 Nov; 276(47):44315-22. PubMed ID: 11551923
[TBL] [Abstract][Full Text] [Related]
11. Molecular interactions regulate BCR signal inhibition by CD22 and CD72.
Nitschke L; Tsubata T
Trends Immunol; 2004 Oct; 25(10):543-50. PubMed ID: 15364057
[TBL] [Abstract][Full Text] [Related]
12. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
[TBL] [Abstract][Full Text] [Related]
13. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
Sato S; Jansen PJ; Tedder TF
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13158-62. PubMed ID: 9371816
[TBL] [Abstract][Full Text] [Related]
14. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
Mizuno K; Tagawa Y; Watanabe N; Ogimoto M; Yakura H
Eur J Immunol; 2005 Feb; 35(2):644-54. PubMed ID: 15668918
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lymphocyte activation by the cell-surface molecule CD22.
Law CL; Sidorenko SP; Clark EA
Immunol Today; 1994 Sep; 15(9):442-9. PubMed ID: 7945784
[TBL] [Abstract][Full Text] [Related]
16. CD22 associates with the human surface IgM-B-cell antigen receptor complex.
Leprince C; Draves KE; Geahlen RL; Ledbetter JA; Clark EA
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3236-40. PubMed ID: 8475064
[TBL] [Abstract][Full Text] [Related]
17. Novel binding site for Src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen.
Zhu C; Sato M; Yanagisawa T; Fujimoto M; Adachi T; Tsubata T
J Biol Chem; 2008 Jan; 283(3):1653-1659. PubMed ID: 18024433
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of CD22 during B cell activation.
Schulte RJ; Campbell MA; Fischer WH; Sefton BM
Science; 1992 Nov; 258(5084):1001-4. PubMed ID: 1279802
[TBL] [Abstract][Full Text] [Related]
19. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
20. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP.
Doody GM; Justement LB; Delibrias CC; Matthews RJ; Lin J; Thomas ML; Fearon DT
Science; 1995 Jul; 269(5221):242-4. PubMed ID: 7618087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]